Italia markets closed

Vistin Pharma ASA (0RAM.L)

LSE - LSE Prezzo differito. Valuta in NOK.
Aggiungi a watchlist
14,27-6,78 (-32,23%)
Alla chiusura: 04:55PM GMT
Schermo intero
Chiusura precedente21,05
Aperto0,00
Denaro0,00 x N/D
Lettera0,00 x N/D
Min-Max giorno0,00 - 0,00
Intervallo di 52 settimane
Volume1.449
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)1,06
Rapporto PE (ttm)0,25
EPS (ttm)0,56
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Vistin Pharma enters into a long-term renewable energy supply agreement with Statkraft

    Oslo, Norway, 9 December 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) announces that it has entered into a long-term industrial energy agreement with Statkraft, the leading Norwegian energy supplier. The agreement will secure a significant part of Vistin’s electricity demand on competitive terms until 2032. The agreement includes Guarantees of Origin as certification of the renewable energy supply, and starts 1.1.2023. 2022 has been very challenging for Vistin and the Norwegian industry,

  • GlobeNewswire

    Vistin Pharma ASA: Third quarter and YTD 2022 financial results

    Oslo, Norway, 26th of October 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the third quarter 2022 Strong revenue growth in the quarter compared to last year. Revenue in the third quarter ended at MNOK 92 compared to MNOK 63 in Q3 2021, a 46% increase. Sales volume in the quarter was up by 19% compared to same quarter last year. The demand in the market for metformin from Vistin is high. However, there were still limitations on volume available for

  • GlobeNewswire

    Vistin Pharma ASA: Invitation to Q3 2022 conference call

    Oslo, Norway, 18 October 2022 Vistin Pharma ASA will release its third quarter and YTD 2022 results on Wednesday 26th of October 2022. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Wednesday 26th of October at 08:30 CET. There will be a Q&A session following the management discussion. The conference call will be held in English. The third quarter conference call will be available via web and audio through the following access points: Webca